表紙:COVID-19迅速抗原検査キットの世界市場 (2022年)
市場調査レポート
商品コード
1073209

COVID-19迅速抗原検査キットの世界市場 (2022年)

Global COVID-19 Rapid Antigen Test Kits Market Research Report 2022

出版日: | 発行: QYResearch | ページ情報: 英文 252 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=130.29円
COVID-19迅速抗原検査キットの世界市場 (2022年)
出版日: 2022年05月07日
発行: QYResearch
ページ情報: 英文 252 Pages
納期: 2~3営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のCOVID-19迅速抗原検査キットの市場規模は、新型コロナウイルス感染症 (COVID-19) による再調整を経て、2022年に615億9,158万米ドル、2028年までに141億5,420万米ドルに達すると予測されています。

一方、予測期間中 (2022年~2028年) のCAGRは-21.74%になると見込まれています。

種類別では、蛍光免疫クロマトグラフィーが2021年に世界市場の81.12%を占めています。地域別に見ると、北米が2021年に27.38%、欧州が45.38%のシェアを占める見通しです。

当レポートでは、世界のCOVID-19迅速抗原検査キットの市場について分析し、種類別・用途別・地域別 (国別) の市場動向の見通し (2020年~2028年)、主要企業のプロファイルなどについて調査しております。

目次

第1章 COVID-19迅速抗原検査キット:市場概要

  • COVID-19迅速抗原検査キット:製品の概要と範囲
  • 種類別のセグメント
    • 販売・成長率の比較:種類別 (2022年~2028年)
    • 蛍光免疫クロマトグラフィー
    • 金コロイド免疫クロマトグラフィー
    • ラテックス免疫クロマトグラフィー
  • 用途別のセグメント
    • 販売の比較:用途別 (2022年~2028年)
    • 病院
    • 家庭
    • 学校
    • 独立系の検査機関
  • 世界のCOVID-19迅速抗原検査キットの市場規模:推定・予測
    • 収益:推定・予測 (2020年~2028年)
    • 販売:推定・予測 (2020年~2028年)
    • 市場規模:地域別 (2020年・2021年・2028年)

第2章 COVID-19迅速抗原検査キット:メーカー別の市場競争

  • 販売・市場シェア:メーカー別 (2020年~2022年)
  • 収益・市場シェア:メーカー別 (2020年~2022年)
  • 平均価格:メーカー別 (2020年~2022年)
  • COVID-19迅速抗原検査キットメーカーの本社・提供エリア・製品種類
  • COVID-19迅速抗原検査キット市場の競争状況と動向
  • メーカーの企業合併・買収 (M&A)、拡張計画

第3章 COVID-19迅速抗原検査キット市場:地域別の遡及的シナリオ

  • 販売の遡及的シナリオ:地域別 (2020年~2022年)
  • 収益の遡及的シナリオ:地域別 (2020年~2022年)
  • 北米のCOVID-19迅速抗原検査キット市場:国別の詳細分析
    • 米国
    • カナダ
  • 欧州のCOVID-19迅速抗原検査キット市場:国別の詳細分析
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
  • アジア太平洋のCOVID-19迅速抗原検査キット市場:地域別の詳細分析
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 東南アジア
  • ラテンアメリカのCOVID-19迅速抗原検査キット市場:国別の詳細分析
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
  • 中東・アフリカのCOVID-19迅速抗原検査キット市場:国別の詳細分析
    • トルコ
    • サウジアラビア
    • アラブ首長国連邦

第4章 COVID-19迅速抗原検査キット:過去の市場分析、種類別

  • 販売・市場シェア:種類別 (2020年~2022年)
  • 収益・市場シェア:種類別 (2020年~2022年)
  • 価格:種類別 (2020年~2022年)

第5章 COVID-19迅速抗原検査キット:過去の市場分析、用途別

  • 販売・市場シェア:用途別 (2020年~2022年)
  • 収益・市場シェア:用途別 (2020年~2022年)
  • 価格:用途別 (2020年~2022年)

第6章 主要企業のプロファイル

  • ABBOTT
    • 企業情報
    • 企業概略・事業概要
    • 販売・収益・粗利益 (2020年~2022年)
    • 製品ポートフォリオ
    • 昨今の動向
  • QUIDEL
  • ACCESS BIO
  • CTK BIOTECH
  • SD BIOSENSOR
  • ELLUME
  • INBIOS
  • CELLTRION
  • AESKU.GROUP
  • ROCHE
  • BD
  • ORASURE TECHNOLOGIES
  • CLIP HEALTH
  • LUMIRADX
  • PRINCETON BIOMEDITECH
  • RAPIGEN INC.
  • ORIENT GENE
  • WONDFO BIOTECH
  • IHEALTH (ANDON HEALTH)
  • WANTAI BIOPHARM
  • BIOTEST BIOTECH
  • SHENZHEN YHLO BIOTECH
  • VAZYME BIOTECH
  • EASYDIAGNOSIS BIOMEDICINE
  • BEIJING HOTGEN BIOTECH
  • ASSURE TECH
  • HANGZHOU ALLTEST BIOTECH
  • ACON BIOTECH
  • BGI GENOMICS
  • LEPU MEDICAL TECHNOLOGY
  • JINWOFU BIOENGINEERING TECHNOLOGY
  • PHASE SCIENTIFIC

第7章 COVID-19迅速抗原検査キットの製造コストの分析

  • COVID-19迅速抗原検査キットの主要原材料の分析
  • 製造コストの構造比率
  • COVID-19迅速抗原検査キットの産業チェーンの分析

第8章 マーケティングチャネル・流通業者・顧客

  • マーケティングチャネル
  • COVID-19迅速抗原検査キットの流通業者の一覧
  • COVID-19迅速抗原検査キットの顧客

第9章 COVID-19迅速抗原検査キット市場:市場力学

  • COVID-19迅速抗原検査キット業界の動向
  • COVID-19迅速抗原検査キットの成長要因
  • COVID-19迅速抗原検査キット市場の課題
  • COVID-19迅速抗原検査キット市場の抑制要因

第10章 世界市場の予測

  • COVID-19迅速抗原検査キット市場:種類別の推計・予測
    • 販売予測:種類別 (2023年~2028年)
    • 収益予測:種類別 (2023年~2028年)
  • COVID-19迅速抗原検査キット市場:用途別の推計・予測
    • 販売予測:用途別 (2023年~2028年)
    • 収益予測:用途別 (2023年~2028年)
  • COVID-19迅速抗原検査キット市場:地域別の推計・予測
    • 販売予測:地域別 (2023年~2028年)
    • 収益予測:地域別 (2023年~2028年)

第11章 調査結果と結論

第12章 調査手法とデータソース

図表

LIST OF TABLES

  • Table 1. Global COVID-19 Rapid Antigen Test Kits Sales Growth Rate Comparison by Type (2022-2028) & (M Units) & (US$ Million)
  • Table 2. Global COVID-19 Rapid Antigen Test Kits Sales Growth Rate Comparison by Application (2022-2028) & (M Units) & (US$ Million)
  • Table 3. Global COVID-19 Rapid Antigen Test Kits Market Size by Region (US$ Million): 2020 VS 2021 VS 2028
  • Table 4. Global COVID-19 Rapid Antigen Test Kits Market Competitive Situation by Manufacturers in 2021
  • Table 5. Global COVID-19 Rapid Antigen Test Kits Sales (M Units) of Key Manufacturers (2020-2022)
  • Table 6. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Manufacturers (2020-2022)
  • Table 7. Global COVID-19 Rapid Antigen Test Kits Revenue (US$ Million) by Manufacturers (2020-2022)
  • Table 8. Global COVID-19 Rapid Antigen Test Kits Revenue Share by Manufacturers (2020-2022)
  • Table 9. Global Market COVID-19 Rapid Antigen Test Kits Average Price (US$/K Units) of Key Manufacturers (2020-2022)
  • Table 10. Manufacturers COVID-19 Rapid Antigen Test Kits Headquarters and Area Served
  • Table 11. Manufacturers COVID-19 Rapid Antigen Test Kits Product Type
  • Table 12. Global Manufacturers Market Concentration Ratio (CR5)
  • Table 13. Global COVID-19 Rapid Antigen Test Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Rapid Antigen Test Kits as of 2021)
  • Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 15. Global COVID-19 Rapid Antigen Test Kits Sales by Region (2020-2022) & (M Units)
  • Table 16. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Region (2020-2022)
  • Table 17. Global COVID-19 Rapid Antigen Test Kits Revenue by Region (2020-2022) & (US$ Million)
  • Table 18. Global COVID-19 Rapid Antigen Test Kits Revenue Market Share by Region (2020-2022)
  • Table 19. North America COVID-19 Rapid Antigen Test Kits Sales by Country (2020-2022) & (M Units)
  • Table 20. North America COVID-19 Rapid Antigen Test Kits Sales Market Share by Country (2020-2022)
  • Table 21. North America COVID-19 Rapid Antigen Test Kits Revenue by Country (2020-2022) & (US$ Million)
  • Table 22. North America COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country (2020-2022)
  • Table 23. Europe COVID-19 Rapid Antigen Test Kits Sales by Country (2020-2022) & (M Units)
  • Table 24. Europe COVID-19 Rapid Antigen Test Kits Sales Market Share by Country (2020-2022)
  • Table 25. Europe COVID-19 Rapid Antigen Test Kits Revenue by Country (2020-2022) & (US$ Million)
  • Table 26. Europe COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country (2020-2022)
  • Table 27. Asia Pacific COVID-19 Rapid Antigen Test Kits Sales by Region (2020-2022) & (M Units)
  • Table 28. Asia Pacific COVID-19 Rapid Antigen Test Kits Sales Market Share by Region (2020-2022)
  • Table 29. Asia Pacific COVID-19 Rapid Antigen Test Kits Revenue by Region (2020-2022) & (US$ Million)
  • Table 30. Asia Pacific COVID-19 Rapid Antigen Test Kits Revenue Market Share by Region (2020-2022)
  • Table 31. Latin America COVID-19 Rapid Antigen Test Kits Sales by Country (2020-2022) & (M Units)
  • Table 32. Latin America COVID-19 Rapid Antigen Test Kits Sales Market Share by Country (2020-2022)
  • Table 33. Latin America COVID-19 Rapid Antigen Test Kits Revenue by Country (2020-2022) & (US$ Million)
  • Table 34. Latin America COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country (2020-2022)
  • Table 35. Middle East and Africa COVID-19 Rapid Antigen Test Kits Sales by Country (2020-2022) & (M Units)
  • Table 36. Middle East and Africa COVID-19 Rapid Antigen Test Kits Sales Market Share by Country (2020-2022)
  • Table 37. Middle East and Africa COVID-19 Rapid Antigen Test Kits Revenue by Country (2020-2022) & (US$ Million)
  • Table 38. Middle East and Africa COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country (2020-2022)
  • Table 39. Global COVID-19 Rapid Antigen Test Kits Sales by Type (2020-2022) & (M Units)
  • Table 40. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Type (2020-2022)
  • Table 41. Global COVID-19 Rapid Antigen Test Kits Revenue by Type (2020-2022) & (US$ Million)
  • Table 42. Global COVID-19 Rapid Antigen Test Kits Revenue Share by Type (2020-2022)
  • Table 43. Global COVID-19 Rapid Antigen Test Kits Price by Type (2020-2022) & (USD/K Units)
  • Table 44. Global COVID-19 Rapid Antigen Test Kits Sales (M Units) by Application (2020-2022)
  • Table 45. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Application (2020-2022)
  • Table 46. Global COVID-19 Rapid Antigen Test Kits Revenue by Application (2020-2022) & (US$ Million)
  • Table 47. Global COVID-19 Rapid Antigen Test Kits Revenue Share by Application (2020-2022)
  • Table 48. Global COVID-19 Rapid Antigen Test Kits Price by Application (2020-2022) & (USD/K Units)
  • Table 49. Abbott Corporation Information
  • Table 50. Abbott Description and Business Overview
  • Table 51. Abbott COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 52. Abbott COVID-19 Rapid Antigen Test Kits Product
  • Table 53. Abbott Recent Developments/Updates
  • Table 54. Quidel Corporation Information
  • Table 55. Quidel Description and Business Overview
  • Table 56. Quidel COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 57. Quidel COVID-19 Rapid Antigen Test Kits Product
  • Table 58. Quidel Recent Developments/Updates
  • Table 59. ACCESS BIO Corporation Information
  • Table 60. ACCESS BIO Description and Business Overview
  • Table 61. ACCESS BIO COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 62. ACCESS BIO COVID-19 Rapid Antigen Test Kits Product
  • Table 63. CTK Biotech Corporation Information
  • Table 64. CTK Biotech Description and Business Overview
  • Table 65. CTK Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 66. CTK Biotech COVID-19 Rapid Antigen Test Kits Product
  • Table 67. CTK Biotech Recent Developments/Updates
  • Table 68. SD Biosensor Corporation Information
  • Table 69. SD Biosensor Description and Business Overview
  • Table 70. SD Biosensor COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 71. SD Biosensor COVID-19 Rapid Antigen Test Kits Product
  • Table 72. Ellume Corporation Information
  • Table 73. Ellume Description and Business Overview
  • Table 74. Ellume COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 75. Ellume COVID-19 Rapid Antigen Test Kits Product
  • Table 76. Ellume Recent Developments/Updates
  • Table 77. InBios Corporation Information
  • Table 78. InBios Description and Business Overview
  • Table 79. InBios COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 80. InBios COVID-19 Rapid Antigen Test Kits Product
  • Table 81. Celltrion Corporation Information
  • Table 82. Celltrion Description and Business Overview
  • Table 83. Celltrion COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 84. Celltrion COVID-19 Rapid Antigen Test Kits Product
  • Table 85. Celltrion Recent Developments/Updates
  • Table 86. AESKU.GROUP Corporation Information
  • Table 87. AESKU.GROUP Description and Business Overview
  • Table 88. AESKU.GROUP COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 89. AESKU.GROUP COVID-19 Rapid Antigen Test Kits Product
  • Table 90. AESKU.GROUP Recent Developments/Updates
  • Table 91. Roche Corporation Information
  • Table 92. Roche Description and Business Overview
  • Table 93. Roche COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 94. Roche COVID-19 Rapid Antigen Test Kits Product
  • Table 95. Roche Recent Developments/Updates
  • Table 96. BD Corporation Information
  • Table 97. BD Description and Business Overview
  • Table 98. BD COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 99. BD COVID-19 Rapid Antigen Test Kits Product
  • Table 100. BD Recent Developments/Updates
  • Table 101. OraSure Technologies Corporation Information
  • Table 102. OraSure Technologies Description and Business Overview
  • Table 103. OraSure Technologies COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 104. OraSure Technologies COVID-19 Rapid Antigen Test Kits Product
  • Table 105. OraSure Technologies Recent Developments/Updates
  • Table 106. Clip Health Corporation Information
  • Table 107. Clip Health Description and Business Overview
  • Table 108. Clip Health COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 109. Clip Health COVID-19 Rapid Antigen Test Kits Product
  • Table 110. LumiraDx Corporation Information
  • Table 111. LumiraDx Description and Business Overview
  • Table 112. LumiraDx COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 113. LumiraDx COVID-19 Rapid Antigen Test Kits Product
  • Table 114. LumiraDx Recent Developments/Updates
  • Table 115. Princeton BioMeditech Corporation Information
  • Table 116. Princeton BioMeditech Description and Business Overview
  • Table 117. Princeton BioMeditech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 118. Princeton BioMeditech COVID-19 Rapid Antigen Test Kits Product
  • Table 119. RapiGEN Inc. Corporation Information
  • Table 120. RapiGEN Inc. Description and Business Overview
  • Table 121. RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 122. RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Product
  • Table 123. Orient Gene Corporation Information
  • Table 124. Orient Gene Description and Business Overview
  • Table 125. Orient Gene COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 126. Orient Gene COVID-19 Rapid Antigen Test Kits Product
  • Table 127. Wondfo Biotech Corporation Information
  • Table 128. Wondfo Biotech Description and Business Overview
  • Table 129. Wondfo Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 130. Ihealth (Andon Health) Corporation Information
  • Table 131. Ihealth (Andon Health) Description and Business Overview
  • Table 132. Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 133. Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Product
  • Table 134. Ihealth (Andon Health) Recent Developments/Updates
  • Table 135. Wantai BioPharm Corporation Information
  • Table 136. Wantai BioPharm Description and Business Overview
  • Table 137. Wantai BioPharm COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 138. Wantai BioPharm COVID-19 Rapid Antigen Test Kits Product
  • Table 139. Biotest Biotech Corporation Information
  • Table 140. Biotest Biotech Description and Business Overview
  • Table 141. Biotest Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 142. Biotest Biotech COVID-19 Rapid Antigen Test Kits Product
  • Table 143. Biotest Biotech Recent Developments/Updates
  • Table 144. Shenzhen YHLO Biotech Corporation Information
  • Table 145. Shenzhen YHLO Biotech Description and Business Overview
  • Table 146. Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 147. Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Product
  • Table 148. Shenzhen YHLO Biotech Recent Developments/Updates
  • Table 149. Vazyme Biotech Corporation Information
  • Table 150. Vazyme Biotech Description and Business Overview
  • Table 151. Vazyme Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 152. Vazyme Biotech COVID-19 Rapid Antigen Test Kits Product
  • Table 153. Vazyme Biotech Recent Developments/Updates
  • Table 154. EasyDiagnosis Biomedicine Corporation Information
  • Table 155. EasyDiagnosis Biomedicine Description and Business Overview
  • Table 156. EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 157. EasyDiagnosis Biomedicine Recent Developments/Updates
  • Table 158. Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 159. Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Product
  • Table 160. Beijing Hotgen Biotech Recent Developments/Updates
  • Table 161. Assure Tech Corporation Information
  • Table 162. Assure Tech Description and Business Overview
  • Table 163. Assure Tech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 164. Assure Tech COVID-19 Rapid Antigen Test Kits Product
  • Table 165. Assure Tech Recent Developments/Updates
  • Table 166. Hangzhou AllTest Biotech Corporation Information
  • Table 167. Hangzhou AllTest Biotech Description and Business Overview
  • Table 168. Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 169. Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Product
  • Table 170. Hangzhou AllTest Biotech Recent Developments/Updates
  • Table 171. ACON Biotech Corporation Information
  • Table 172. ACON Biotech Description and Business Overview
  • Table 173. ACON Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 174. ACON Biotech COVID-19 Rapid Antigen Test Kits Product
  • Table 175. ACON Biotech Recent Developments/Updates
  • Table 176. BGI Genomics Corporation Information
  • Table 177. BGI Description and Business Overview
  • Table 178. BGI Genomics COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 179. BGI Genomics COVID-19 Rapid Antigen Test Kits Product
  • Table 180. BGI Genomics Recent Developments/Updates
  • Table 181. Lepu Medical Technology Corporation Information
  • Table 182. Lepu Medical Technology Description and Business Overview
  • Table 183. Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 184. Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Product
  • Table 185. Lepu Medical Technology Recent Developments/Updates
  • Table 186. Jinwofu Bioengineering Technology Corporation Information
  • Table 187. Jinwofu Bioengineering Technology Description and Business Overview
  • Table 188. Jinwofu Bioengineering Technology COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 189. Jinwofu Bioengineering Technology COVID-19 Rapid Antigen Test Kits Product
  • Table 190. Jinwofu Bioengineering Technology Recent Developments/Updates
  • Table 191. Phase Scientific Corporation Information
  • Table 192. Phase Scientific Description and Business Overview
  • Table 193. Phase Scientific COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2022)
  • Table 194. Phase Scientific COVID-19 Rapid Antigen Test Kits Product
  • Table 195. Phase Scientific Recent Developments/Updates
  • Table 196. Key Suppliers of Raw Materials
  • Table 197. COVID-19 Rapid Antigen Test Kits Distributors List
  • Table 198. COVID-19 Rapid Antigen Test Kits Customers List
  • Table 199. COVID-19 Rapid Antigen Test Kits Market Trends
  • Table 200. COVID-19 Rapid Antigen Test Kits Market Drivers
  • Table 201. COVID-19 Rapid Antigen Test Kits Market Challenges
  • Table 202. COVID-19 Rapid Antigen Test Kits Market Restraints
  • Table 203. Global COVID-19 Rapid Antigen Test Kits Sales Forecast by Type (2023-2028) & (M Units)
  • Table 204. Global COVID-19 Rapid Antigen Test Kits Sales Market Share Forecast by Type (2023-2028)
  • Table 205. Global COVID-19 Rapid Antigen Test Kits Revenue Forecast by Type (2023-2028) & (US$ Million)
  • Table 206. Global COVID-19 Rapid Antigen Test Kits Revenue Market Share Forecast by Type (2023-2028)
  • Table 207. Global COVID-19 Rapid Antigen Test Kits Sales Forecast by Application (2023-2028) & (M Units)
  • Table 208. Global COVID-19 Rapid Antigen Test Kits Sales Market Share Forecast by Application (2023-2028)
  • Table 209. Global COVID-19 Rapid Antigen Test Kits Revenue Forecast by Application (2023-2028) & (US$ Million)
  • Table 210. Global COVID-19 Rapid Antigen Test Kits Revenue Market Share Forecast by Application (2023-2028)
  • Table 211. Global COVID-19 Rapid Antigen Test Kits Sales Forecast by Region (2023-2028) & (M Units)
  • Table 212. Global COVID-19 Rapid Antigen Test Kits Sales Market Share Forecast by Region (2023-2028)
  • Table 213. Global COVID-19 Rapid Antigen Test Kits Revenue Forecast by Region (2023-2028) & (US$ Million)
  • Table 214. Global COVID-19 Rapid Antigen Test Kits Revenue Market Share Forecast by Region (2023-2028)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Product Picture of COVID-19 Rapid Antigen Test Kits
  • Figure 2. Global COVID-19 Rapid Antigen Test Kits Market Share by Type: 2022 & 2028
  • Figure 3. Fluorescence Immunochromatography Product Picture
  • Figure 4. Colloidal Gold Immunochromatography Product Picture
  • Figure 5. Latex Immunochromatography Product Picture
  • Figure 6. Global COVID-19 Rapid Antigen Test Kits Market Share by Application: 2022 & 2028
  • Figure 7. Hospital
  • Figure 8. Home
  • Figure 9. School
  • Figure 10. Third-Party Detection Institution
  • Figure 11. Global COVID-19 Rapid Antigen Test Kits Revenue, (US$ Million), 2020 VS 2021 VS 2028
  • Figure 12. Global COVID-19 Rapid Antigen Test Kits Market Size (2020-2028) & (US$ Million)
  • Figure 13. Global COVID-19 Rapid Antigen Test Kits Sales (2020-2028) & (M Units)
  • Figure 14. COVID-19 Rapid Antigen Test Kits Sales Share by Manufacturers in 2021
  • Figure 15. Global COVID-19 Rapid Antigen Test Kits Revenue Share by Manufacturers in 2021
  • Figure 16. Global 5 and 10 Largest COVID-19 Rapid Antigen Test Kits Players: Market Share by Revenue in COVID-19 Rapid Antigen Test Kits in 2021
  • Figure 17. North America COVID-19 Rapid Antigen Test Kits Sales Market Share by Country in 2021
  • Figure 18. North America COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country in 2021
  • Figure 19. United States COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 20. Canada COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 21. Europe COVID-19 Rapid Antigen Test Kits Sales Market Share by Country in 2021
  • Figure 22. Europe COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country in 2021
  • Figure 23. Germany COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 24. France COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 25. U.K. COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 26. Italy COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 27. Russia COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 28. Asia Pacific COVID-19 Rapid Antigen Test Kits Sales Market Share by Region in 2021
  • Figure 29. Asia Pacific COVID-19 Rapid Antigen Test Kits Revenue Market Share by Region in 2021
  • Figure 30. China COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 31. Japan COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 32. South Korea COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 33. India COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 34. Australia COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 35. Southeast Asia COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 36. Latin America COVID-19 Rapid Antigen Test Kits Sales Market Share by Country in 2021
  • Figure 37. Latin America COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country in 2021
  • Figure 38. Brazil COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 39. Mexico COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 40. Argentina COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 41. Colombia COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 42. Middle East and Africa COVID-19 Rapid Antigen Test Kits Sales Market Share by Country in 2021
  • Figure 43. Middle East and Africa COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country in 2021
  • Figure 44. Turkey COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 45. Saudi Arabia COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 46. UAE COVID-19 Rapid Antigen Test Kits Revenue Growth Rate (2020-2022) & (US$ Million)
  • Figure 47. Sales Market Share of COVID-19 Rapid Antigen Test Kits by Type (2020-2022)
  • Figure 48. Revenue Market Share of COVID-19 Rapid Antigen Test Kits by Type (2020-2022)
  • Figure 49. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Application (2020-2022)
  • Figure 50. Global COVID-19 Rapid Antigen Test Kits Revenue Share by Application (2020-2022)
  • Figure 51. Manufacturing Cost Structure of COVID-19 Rapid Antigen Test Kits
  • Figure 52. COVID-19 Rapid Antigen Test Kits Industrial Chain Analysis
  • Figure 53. Channels of Distribution
  • Figure 54. Distributors Profiles
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed
目次

Due to the COVID-19 pandemic, the global COVID-19 Rapid Antigen Test Kits market size is estimated to be worth US$ 61,591.58 million in 2022 and is forecast to a readjusted size of US$ 14,154.20 million by 2028 with a CAGR of -21.74% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Fluorescence Immunochromatography accounting for 81.12% of the COVID-19 Rapid Antigen Test Kits global market in 2021, is projected to value US$ 11,227.11 million by 2028, growing at a revised -19.86% CAGR from 2022 to 2028. While Hospital segment is altered to an -20.53% CAGR throughout this forecast period.

North America COVID-19 Rapid Antigen Test Kits market size was US$ 7,673.09 million in 2021, while Europe was US$ 12,722.08 million. The proportion of the North America was 27.38% in 2021, while Europe's percentage was 45.38%, and it is predicted that Europe market share will reach 24.64% in 2028, trailing a CAGR of -23.12% through the analysis period.

The global major manufacturers of COVID-19 Rapid Antigen Test Kits include Abbott, ROCHE, SD Biosensor, Orient Gene, BD, Quidel, Beijing Hotgen Biotech, ACON Biotech, Celltrion, Jinwofu Bioengineering Technology, LumiraDx, ACCESS BIO, EasyDiagnosis Biomedicine, Ellume, Wantai BioPharm, Clip Health, Hangzhou AllTest Biotech, Ihealth (Andon Health), Biotest Biotech, Phase Scientific, BGI Genomics, Wondfo Biotech, Assure Tech, Lepu Medical Technology, RapiGEN Inc., etc. In terms of revenue, the global three largest players hold a 37.29% market share of COVID-19 Rapid Antigen Test Kits in 2021.

This report focuses on COVID-19 Rapid Antigen Test Kits volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall COVID-19 Rapid Antigen Test Kits market size by analysing historical data and future prospect.

Segment Analysis:

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2020 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment Analysis:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2020 to 2028. by Application segment also provides consumption during the forecast period of 2020 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

  • Abbott
  • Quidel
  • ACCESS BIO
  • CTK Biotech
  • SD Biosensor
  • Ellume
  • InBios
  • Celltrion
  • AESKU.GROUP
  • ROCHE
  • BD
  • OraSure Technologies
  • Clip Health
  • LumiraDx
  • Princeton BioMeditech Corporation
  • RapiGEN Inc.
  • Orient Gene
  • Wondfo Biotech
  • Ihealth (Andon Health)
  • Wantai BioPharm
  • Biotest Biotech
  • Shenzhen YHLO Biotech
  • Vazyme Biotech
  • EasyDiagnosis Biomedicine
  • Beijing Hotgen Biotech
  • Assure Tech
  • Hangzhou AllTest Biotech
  • ACON Biotech
  • BGI Genomics
  • Lepu Medical Technology
  • Jinwofu Bioengineering Technology
  • Phase Scientific

Segment by Type

  • Fluorescence Immunochromatography
  • Colloidal Gold Immunochromatography
  • Latex Immunochromatography
  • Others

Segment by Application

  • Hospital
  • Home
  • School
  • Third-Party Detection Institution
  • Others

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Southeast Asia
    • Other Regions
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • U.A.E
  • Other Regions

TABLE OF CONTENTS

1 COVID-19 RAPID ANTIGEN TEST KITS MARKET OVERVIEW

  • 1.1 PRODUCT OVERVIEW AND SCOPE OF COVID-19 RAPID ANTIGEN TEST KITS
  • 1.2 COVID-19 RAPID ANTIGEN TEST KITS SEGMENT BY TYPE
    • 1.2.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES GROWTH RATE COMPARISON BY TYPE (2022-2028)
    • 1.2.2 FLUORESCENCE IMMUNOCHROMATOGRAPHY
    • 1.2.3 COLLOIDAL GOLD IMMUNOCHROMATOGRAPHY
    • 1.2.4 LATEX IMMUNOCHROMATOGRAPHY
  • 1.3 COVID-19 RAPID ANTIGEN TEST KITS SEGMENT BY APPLICATION
    • 1.3.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES COMPARISON BY APPLICATION (2022-2028)
    • 1.3.2 HOSPITAL
    • 1.3.3 HOME
    • 1.3.4 SCHOOL
    • 1.3.5 THIRD-PARTY DETECTION INSTITUTION
  • 1.4 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET SIZE ESTIMATES AND FORECASTS
    • 1.4.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS REVENUE 2020-2028
    • 1.4.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES 2020-2028
    • 1.4.3 COVID-19 RAPID ANTIGEN TEST KITS MARKET SIZE BY REGION: 2020 VERSUS 2021 VERSUS 2028

2 COVID-19 RAPID ANTIGEN TEST KITS MARKET COMPETITION BY MANUFACTURERS

  • 2.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES MARKET SHARE BY MANUFACTURERS (2020-2022)
  • 2.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS REVENUE MARKET SHARE BY MANUFACTURERS (2020-2022)
  • 2.3 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS AVERAGE PRICE BY MANUFACTURERS (2020-2022)
  • 2.4 MANUFACTURERS COVID-19 RAPID ANTIGEN TEST KITS HEADQUARTERS, AREA SERVED, PRODUCT TYPE
  • 2.5 COVID-19 RAPID ANTIGEN TEST KITS MARKET COMPETITIVE SITUATION AND TRENDS
    • 2.5.1 COVID-19 RAPID ANTIGEN TEST KITS MARKET CONCENTRATION RATE
    • 2.5.2 THE GLOBAL 5 AND 10 LARGEST COVID-19 RAPID ANTIGEN TEST KITS PLAYERS MARKET SHARE BY REVENUE
    • 2.5.3 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)
  • 2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS

3 COVID-19 RAPID ANTIGEN TEST KITS RETROSPECTIVE MARKET SCENARIO BY REGION

  • 3.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2020-2022
  • 3.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2020-2022
  • 3.3 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY COUNTRY
    • 3.3.1 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS SALES BY COUNTRY
    • 3.3.2 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY COUNTRY
    • 3.3.3 UNITED STATES
    • 3.3.4 CANADA
  • 3.4 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY COUNTRY
    • 3.4.1 EUROPE COVID-19 RAPID ANTIGEN TEST KITS SALES BY COUNTRY
    • 3.4.2 EUROPE COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY COUNTRY
    • 3.4.3 GERMANY
    • 3.4.4 FRANCE
    • 3.4.5 U.K.
    • 3.4.6 ITALY
    • 3.4.7 RUSSIA
  • 3.5 ASIA PACIFIC COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY REGION
    • 3.5.1 ASIA PACIFIC COVID-19 RAPID ANTIGEN TEST KITS SALES BY REGION
    • 3.5.2 ASIA PACIFIC COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY REGION
    • 3.5.3 CHINA
    • 3.5.4 JAPAN
    • 3.5.5 SOUTH KOREA
    • 3.5.6 INDIA
    • 3.5.7 AUSTRALIA
    • 3.5.8 SOUTHEAST ASIA
  • 3.6 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY COUNTRY
    • 3.6.1 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS SALES BY COUNTRY
    • 3.6.2 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY COUNTRY
    • 3.6.3 BRAZIL
    • 3.6.4 MEXICO
    • 3.6.5 ARGENTINA
    • 3.6.6 COLOMBIA
  • 3.7 MIDDLE EAST AND AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY COUNTRY
    • 3.7.1 MIDDLE EAST AND AFRICA COVID-19 RAPID ANTIGEN TEST KITS SALES BY COUNTRY
    • 3.7.2 MIDDLE EAST AND AFRICA COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY COUNTRY
    • 3.7.3 TURKEY
    • 3.7.4 SAUDI ARABIA
    • 3.7.5 UAE

4 COVID-19 RAPID ANTIGEN TEST KITS HISTORIC MARKET ANALYSIS BY TYPE

  • 4.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES MARKET SHARE BY TYPE (2020-2022)
  • 4.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS REVENUE MARKET SHARE BY TYPE (2020-2022)
  • 4.3 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS PRICE BY TYPE (2020-2022)

5 COVID-19 RAPID ANTIGEN TEST KITS HISTORIC MARKET ANALYSIS BY APPLICATION

  • 5.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES MARKET SHARE BY APPLICATION (2020-2022)
  • 5.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS REVENUE MARKET SHARE BY APPLICATION (2020-2022)
  • 5.3 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS PRICE BY APPLICATION (2020-2022)

6 KEY COMPANIES PROFILED

  • 6.1 ABBOTT
    • 6.1.1 ABBOTT CORPORATION INFORMATION
    • 6.1.2 ABBOTT DESCRIPTION AND BUSINESS OVERVIEW
    • 6.1.3 ABBOTT COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.1.4 ABBOTT COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.1.5 ABBOTT RECENT DEVELOPMENTS/UPDATES
  • 6.2 QUIDEL
    • 6.2.1 QUIDEL CORPORATION INFORMATION
    • 6.2.2 QUIDEL DESCRIPTION AND BUSINESS OVERVIEW
    • 6.2.3 QUIDEL COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.2.4 QUIDEL COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.2.5 QUIDEL RECENT DEVELOPMENTS/UPDATES
  • 6.3 ACCESS BIO
    • 6.3.1 ACCESS BIO CORPORATION INFORMATION
    • 6.3.2 ACCESS BIO DESCRIPTION AND BUSINESS OVERVIEW
    • 6.3.3 ACCESS BIO COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.3.4 ACCESS BIO COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
  • 6.4 CTK BIOTECH
    • 6.4.1 CTK BIOTECH CORPORATION INFORMATION
    • 6.4.2 CTK BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.4.3 CTK BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.4.4 CTK BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.4.5 CTK BIOTECH RECENT DEVELOPMENTS/UPDATES
  • 6.5 SD BIOSENSOR
    • 6.5.1 SD BIOSENSOR CORPORATION INFORMATION
    • 6.5.2 SD BIOSENSOR DESCRIPTION AND BUSINESS OVERVIEW
    • 6.5.3 SD BIOSENSOR COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.5.4 SD BIOSENSOR COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
  • 6.6 ELLUME
    • 6.6.1 ELLUME CORPORATION INFORMATION
    • 6.6.2 ELLUME DESCRIPTION AND BUSINESS OVERVIEW
    • 6.6.3 ELLUME COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.6.4 ELLUME COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.6.5 ELLUME RECENT DEVELOPMENTS/UPDATES
  • 6.7 INBIOS
    • 6.7.1 INBIOS CORPORATION INFORMATION
    • 6.7.2 INBIOS DESCRIPTION AND BUSINESS OVERVIEW
    • 6.7.3 INBIOS COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.7.4 INBIOS COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
  • 6.8 CELLTRION
    • 6.8.1 CELLTRION CORPORATION INFORMATION
    • 6.8.2 CELLTRION DESCRIPTION AND BUSINESS OVERVIEW
    • 6.8.3 CELLTRION COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.8.4 CELLTRION COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.8.5 CELLTRION RECENT DEVELOPMENTS/UPDATES
  • 6.9 AESKU.GROUP
    • 6.9.1 AESKU.GROUP CORPORATION INFORMATION
    • 6.9.2 AESKU.GROUP DESCRIPTION AND BUSINESS OVERVIEW
    • 6.9.3 AESKU.GROUP COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.9.4 AESKU.GROUP COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.9.5 AESKU.GROUP RECENT DEVELOPMENTS/UPDATES
  • 6.10 ROCHE
    • 6.10.1 ROCHE CORPORATION INFORMATION
    • 6.10.2 ROCHE DESCRIPTION AND BUSINESS OVERVIEW
    • 6.10.3 ROCHE COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.10.4 ROCHE COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.10.5 ROCHE RECENT DEVELOPMENTS/UPDATES
  • 6.11 BD
    • 6.11.1 BD CORPORATION INFORMATION
    • 6.11.2 BD DESCRIPTION AND BUSINESS OVERVIEW
    • 6.11.3 BD COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.11.4 BD COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.11.5 BD RECENT DEVELOPMENTS/UPDATES
  • 6.12 ORASURE TECHNOLOGIES
    • 6.12.1 ORASURE TECHNOLOGIES CORPORATION INFORMATION
    • 6.12.2 ORASURE TECHNOLOGIES DESCRIPTION AND BUSINESS OVERVIEW
    • 6.12.3 ORASURE TECHNOLOGIES COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.12.4 ORASURE TECHNOLOGIES COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.12.5 ORASURE TECHNOLOGIES RECENT DEVELOPMENTS/UPDATES
  • 6.13 CLIP HEALTH
    • 6.13.1 CLIP HEALTH CORPORATION INFORMATION
    • 6.13.2 CLIP HEALTH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.13.3 CLIP HEALTH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.13.4 CLIP HEALTH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
  • 6.14 LUMIRADX
    • 6.14.1 LUMIRADX CORPORATION INFORMATION
    • 6.14.2 LUMIRADX DESCRIPTION AND BUSINESS OVERVIEW
    • 6.14.3 LUMIRADX COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.14.4 LUMIRADX COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.14.5 LUMIRADX RECENT DEVELOPMENTS/UPDATES
  • 6.15 PRINCETON BIOMEDITECH
    • 6.15.1 PRINCETON BIOMEDITECH CORPORATION INFORMATION
    • 6.15.2 PRINCETON BIOMEDITECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.15.3 PRINCETON BIOMEDITECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.15.4 PRINCETON BIOMEDITECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
  • 6.16 RAPIGEN INC.
    • 6.16.1 RAPIGEN INC. CORPORATION INFORMATION
    • 6.16.2 RAPIGEN INC. DESCRIPTION AND BUSINESS OVERVIEW
    • 6.16.3 RAPIGEN INC. COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.16.4 RAPIGEN INC. COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
  • 6.17 ORIENT GENE
    • 6.17.1 ORIENT GENE CORPORATION INFORMATION
    • 6.17.2 ORIENT GENE DESCRIPTION AND BUSINESS OVERVIEW
    • 6.17.3 ORIENT GENE COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.17.4 ORIENT GENE COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
  • 6.18 WONDFO BIOTECH
    • 6.18.1 WONDFO BIOTECH CORPORATION INFORMATION
    • 6.18.2 WONDFO BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.18.3 WONDFO BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.18.4 WONDFO BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
  • 6.19 IHEALTH (ANDON HEALTH)
    • 6.19.1 IHEALTH (ANDON HEALTH) CORPORATION INFORMATION
    • 6.19.2 IHEALTH (ANDON HEALTH) DESCRIPTION AND BUSINESS OVERVIEW
    • 6.19.3 IHEALTH (ANDON HEALTH) COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.19.4 IHEALTH (ANDON HEALTH) COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.19.5 IHEALTH (ANDON HEALTH) RECENT DEVELOPMENTS/UPDATES
  • 6.20 WANTAI BIOPHARM
    • 6.20.1 WANTAI BIOPHARM CORPORATION INFORMATION
    • 6.20.2 WANTAI BIOPHARM DESCRIPTION AND BUSINESS OVERVIEW
    • 6.20.3 WANTAI BIOPHARM COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.20.4 WANTAI BIOPHARM COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
  • 6.21 BIOTEST BIOTECH
    • 6.21.1 BIOTEST BIOTECH CORPORATION INFORMATION
    • 6.21.2 BIOTEST BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.21.3 BIOTEST BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.21.4 BIOTEST BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.21.5 BIOTEST BIOTECH RECENT DEVELOPMENTS/UPDATES
  • 6.22 SHENZHEN YHLO BIOTECH
    • 6.22.1 SHENZHEN YHLO BIOTECH CORPORATION INFORMATION
    • 6.22.2 SHENZHEN YHLO BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.22.3 SHENZHEN YHLO BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.22.4 SHENZHEN YHLO BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.22.5 SHENZHEN YHLO BIOTECH RECENT DEVELOPMENTS/UPDATES
  • 6.23 VAZYME BIOTECH
    • 6.23.1 VAZYME BIOTECH CORPORATION INFORMATION
    • 6.23.2 VAZYME BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.23.3 VAZYME BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.23.4 VAZYME BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.23.5 VAZYME BIOTECH RECENT DEVELOPMENTS/UPDATES
  • 6.24 EASYDIAGNOSIS BIOMEDICINE
    • 6.24.1 EASYDIAGNOSIS BIOMEDICINE CORPORATION INFORMATION
    • 6.24.2 EASYDIAGNOSIS BIOMEDICINE DESCRIPTION AND BUSINESS OVERVIEW
    • 6.24.3 EASYDIAGNOSIS BIOMEDICINE COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.24.4 EASYDIAGNOSIS BIOMEDICINE COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.24.5 EASYDIAGNOSIS BIOMEDICINE RECENT DEVELOPMENTS/UPDATES
  • 6.25 BEIJING HOTGEN BIOTECH
    • 6.25.1 BEIJING HOTGEN BIOTECH CORPORATION INFORMATION
    • 6.25.2 BEIJING HOTGEN BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.25.3 BEIJING HOTGEN BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.25.4 BEIJING HOTGEN BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.25.5 BEIJING HOTGEN BIOTECH RECENT DEVELOPMENTS/UPDATES
  • 6.26 ASSURE TECH
    • 6.26.1 ASSURE TECH CORPORATION INFORMATION
    • 6.26.2 ASSURE TECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.26.3 ASSURE TECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.26.4 ASSURE TECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.26.5 ASSURE TECH RECENT DEVELOPMENTS/UPDATES
  • 6.27 HANGZHOU ALLTEST BIOTECH
    • 6.27.1 HANGZHOU ALLTEST BIOTECH CORPORATION INFORMATION
    • 6.27.2 HANGZHOU ALLTEST BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.27.3 HANGZHOU ALLTEST BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.27.4 HANGZHOU ALLTEST BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.27.5 HANGZHOU ALLTEST BIOTECH RECENT DEVELOPMENTS/UPDATES
  • 6.28 ACON BIOTECH
    • 6.28.1 ACON BIOTECH CORPORATION INFORMATION
    • 6.28.2 ACON BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.28.3 ACON BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.28.4 ACON BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.28.5 ACON BIOTECH RECENT DEVELOPMENTS/UPDATES
  • 6.29 BGI GENOMICS
    • 6.29.1 BGI GENOMICS CORPORATION INFORMATION
    • 6.29.2 BGI GENOMICS DESCRIPTION AND BUSINESS OVERVIEW
    • 6.29.3 BGI GENOMICS COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.29.4 BGI GENOMICS COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.29.5 BGI GENOMICS RECENT DEVELOPMENTS/UPDATES
  • 6.30 LEPU MEDICAL TECHNOLOGY
    • 6.30.1 LEPU MEDICAL TECHNOLOGY CORPORATION INFORMATION
    • 6.30.2 LEPU MEDICAL TECHNOLOGY DESCRIPTION AND BUSINESS OVERVIEW
    • 6.30.3 LEPU MEDICAL TECHNOLOGY COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.30.4 LEPU MEDICAL TECHNOLOGY COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.30.5 LEPU MEDICAL TECHNOLOGY RECENT DEVELOPMENTS/UPDATES
  • 6.31 JINWOFU BIOENGINEERING TECHNOLOGY
    • 6.31.1 JINWOFU BIOENGINEERING TECHNOLOGY CORPORATION INFORMATION
    • 6.31.2 JINWOFU BIOENGINEERING TECHNOLOGY DESCRIPTION AND BUSINESS OVERVIEW
    • 6.31.3 JINWOFU BIOENGINEERING TECHNOLOGY COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.31.4 JINWOFU BIOENGINEERING TECHNOLOGY COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.31.5 JINWOFU BIOENGINEERING TECHNOLOGY RECENT DEVELOPMENTS/UPDATES
  • 6.32 PHASE SCIENTIFIC
    • 6.32.1 PHASE SCIENTIFIC CORPORATION INFORMATION
    • 6.32.2 PHASE SCIENTIFIC DESCRIPTION AND BUSINESS OVERVIEW
    • 6.32.3 PHASE SCIENTIFIC COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 6.32.4 PHASE SCIENTIFIC COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO
    • 6.32.5 PHASE SCIENTIFIC RECENT DEVELOPMENTS/UPDATES

7 COVID-19 RAPID ANTIGEN TEST KITS MANUFACTURING COST ANALYSIS

  • 7.1 COVID-19 RAPID ANTIGEN TEST KITS KEY RAW MATERIALS ANALYSIS
    • 7.1.1 KEY RAW MATERIALS
    • 7.1.2 KEY SUPPLIERS OF RAW MATERIALS
  • 7.2 PROPORTION OF MANUFACTURING COST STRUCTURE
  • 7.3 COVID-19 RAPID ANTIGEN TEST KITS INDUSTRIAL CHAIN ANALYSIS

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

  • 8.1 MARKETING CHANNEL
  • 8.2 COVID-19 RAPID ANTIGEN TEST KITS DISTRIBUTORS LIST
  • 8.3 COVID-19 RAPID ANTIGEN TEST KITS CUSTOMERS

9 COVID-19 RAPID ANTIGEN TEST KITS MARKET DYNAMICS

  • 9.1 COVID-19 RAPID ANTIGEN TEST KITS INDUSTRY TRENDS
  • 9.2 COVID-19 RAPID ANTIGEN TEST KITS MARKET DRIVERS
  • 9.3 COVID-19 RAPID ANTIGEN TEST KITS MARKET CHALLENGES
  • 9.4 COVID-19 RAPID ANTIGEN TEST KITS MARKET RESTRAINTS

10 GLOBAL MARKET FORECAST

  • 10.1 COVID-19 RAPID ANTIGEN TEST KITS MARKET ESTIMATES AND PROJECTIONS BY TYPE
    • 10.1.1 GLOBAL FORECASTED SALES OF COVID-19 RAPID ANTIGEN TEST KITS BY TYPE (2023-2028)
    • 10.1.2 GLOBAL FORECASTED REVENUE OF COVID-19 RAPID ANTIGEN TEST KITS BY TYPE (2023-2028)
  • 10.2 COVID-19 RAPID ANTIGEN TEST KITS MARKET ESTIMATES AND PROJECTIONS BY APPLICATION
    • 10.2.1 GLOBAL FORECASTED SALES OF COVID-19 RAPID ANTIGEN TEST KITS BY APPLICATION (2023-2028)
    • 10.2.2 GLOBAL FORECASTED REVENUE OF COVID-19 RAPID ANTIGEN TEST KITS BY APPLICATION (2023-2028)
  • 10.3 COVID-19 RAPID ANTIGEN TEST KITS MARKET ESTIMATES AND PROJECTIONS BY REGION
    • 10.3.1 GLOBAL FORECASTED SALES OF COVID-19 RAPID ANTIGEN TEST KITS BY REGION (2023-2028)
    • 10.3.2 GLOBAL FORECASTED REVENUE OF COVID-19 RAPID ANTIGEN TEST KITS BY REGION (2023-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

  • 12.1 METHODOLOGY/RESEARCH APPROACH
    • 12.1.1 RESEARCH PROGRAMS/DESIGN
    • 12.1.2 MARKET SIZE ESTIMATION
    • 12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 12.2 DATA SOURCE
    • 12.2.1 SECONDARY SOURCES
    • 12.2.2 PRIMARY SOURCES
  • 12.3 AUTHOR LIST
  • 12.4 DISCLAIMER 226